Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies (Q34093216)

31 July 2017

1 reference

title

Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies. (English)

1 reference

31 July 2017

0 references

0 references

Tauscher J

1

1 reference

31 July 2017

Kapur S

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

15

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

671-678

1 reference

Dosage of haloperidol for schizophrenia

31 July 2017

cites work

1 reference

12 December 2020

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

1 reference

12 December 2020

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

12 December 2020

Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations

1 reference

12 December 2020

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

12 December 2020

High vs standard dosage fluphenazine HCL in acute schizophrenia

1 reference

12 December 2020

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

12 December 2020

The risks and benefits of clozapine versus chlorpromazine

1 reference

12 December 2020

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine

1 reference

12 December 2020

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

1 reference

12 December 2020

Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings]

1 reference

12 December 2020

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

12 December 2020

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Pharmacotherapy of first-episode schizophrenia

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

12 December 2020

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

12 December 2020

Sertindole and dopamine D 2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123 I-IBZM SPECT study

1 reference

12 December 2020

Neuroleptic Plasma Levels

1 reference

12 December 2020

Targets for neurotransmitter receptor research using PET scan: the neuroleptic binding site

1 reference

12 December 2020

D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients

1 reference

12 December 2020

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

1 reference

12 December 2020

D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects

1 reference

12 December 2020

Practice guideline for the treatment of patients with delirium. American Psychiatric Association

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

12 December 2020

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

12 December 2020

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench

1 reference

12 December 2020

Haloperidol for acute schizophrenic patients. An evaluation of three oral regimens

1 reference

12 December 2020

Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs

1 reference

12 December 2020

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

1 reference

12 December 2020

Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients

1 reference

12 December 2020

Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.2165/00023210-200115090-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1053070339

0 references

1 reference